首页> 外文期刊>Journal of Chemistry >Quantitative Analysis of Lorazepam in Pharmaceutical Formulation Through FTIR Spectroscopy
【24h】

Quantitative Analysis of Lorazepam in Pharmaceutical Formulation Through FTIR Spectroscopy

机译:通过FTIR光谱法测定药物制剂中洛拉西泮的定量分析

获取原文
           

摘要

A Fourier transform infrared (FTIR) spectrophotometric method was development for the rapid, direct measurement of lorazepam in different pharmaceutical products. The method involves the off-line extraction of lorazepam with sonication and direct determination in the extract through peak height measurement in the 1704 cm-1using a baseline correction between 1850 and 1550 cm-1. For standardization an external calibration line established from standard solutions of lorazepam in chloroform were used. The method provides a limit of detection of 0.0030 mg per tablet (n=5), a relative standard deviation (RSD) of 2.65% for 5 independent measurement of standard solution at a concentration level of 1 mgg-1. Result obtained by FTIR agrees with those obtained by a reference methodology based on ultraviolet spectrometry and thus the developed procedure offers a good alternative for the determination of lorazepam in commercial products.
机译:傅里叶变换红外(FTIR)分光光度法是在不同药物产品中的快速直接测量洛拉西泮的开发。该方法涉及Lorazepam的离线提取,通过在1704cm-1在1850和1550cm-1之间的基线校正中通过峰值高度测量在提取物中的超声提取和直接测定。对于标准化,使用从氯仿中的洛拉西菊酯的标准溶液建立的外部校准线。该方法提供每片(n = 5)0.0030mg的检测限,相对标准偏差(RSD)为2.65%,对于5个独立测量标准溶液的浓度水平为1 MGG-1。由FTIR获得的结果与基于紫外光谱法的参考方法获得的结果同意,因此开发的程序提供了良好的替代品,用于在商业产品中测定洛拉西泮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号